2026 Glaucoma Report

Learn how glaucoma surgeons can integrate canal-based procedures into their practice and complement existing MIGS techniques for improved IOP control.

Join Drs. Singh and Quezada-Ruiz as they discuss advancements in treating Stargardt disease and other retinal conditions with oral gildeuretinol.

Consider approaches optometrists can take in reducing contact lens dropout to improve practice profitability and patient satisfaction.

Biotech company emerges from stealth with Series B financing supporting FIH trial initiation for ETHY-001, an anti-TSHR antibody for TED and Graves’ disease.

Next up: a 60-day review period ahead of a potential PDUFA target action date assignment; could become the first FDA-approved treatment for Stargardt.

The PF formulation debuts 9 months after securing FDA approval with a patented mucoadhesive lubricating gel technology for IOP reduction.

Consider ocular manifestations of traumatic brain injury to screen patients for and download the cheat sheet with a red flags checklist and diagnostic testing.

Join Drs. Gupta and Weissman in their discussion on optimizing the ocular surface before cataract surgery for consistent outcomes and improved patient satisfaction.

Review how optometrists can educate patients on and integrate nutritional support into age-related macular degeneration (AMD) management.

Review the state and future of the soft contact lens market and how optometrists can empower practice staff to increase contact lens sales.

Join Drs. Lang, Leung, and Dang as they discuss what it means to be a KOL and how to engage with industry with clinical integrity.

Sit down with Dr. De Rojas as he discusses the current and future impact of artificial intelligence (AI) in ophthalmology and how he uses AI in his practice.